Neuromyelitis optica is a rare chronic condition that causes eye pain and even vision loss. This disease happens when your own immune system attacks your nervous system. In this article, we look at ...

The early diagnosis and treatment of neuromyelitis optica (NMO) generally improve the outlook for people with this condition. Corticosteroids and immunotherapy are the main treatment options. NMO, ...

Autoimmune diseases are the molecular equivalent of "friendly fire": The body attacks itself instead of harmful invaders. Now, researchers from Japan have found that interrupting the complex interplay ...

New diagnostic criteria have been introduced for neuromyelitis optica (NMO), which is now to be known as neuromyelitis optica spectrum disorder (NMOSD). The new criteria were developed by an ...

SAN DIEGO — Treatment with daratumumab, a monoclonal antibody approved to treat multiple myeloma, was associated with a significant decrease in relapse risk in patients with aquaporin-4 immunoglobulin ...

It can look like multiple sclerosis (MS), act like MS, and feel like MS. And until recently, neuromyelitis optica spectrum disorder (NMOSD) was often misdiagnosed as MS, a situation that could have ...

Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease in which the immune system attacks the central nervous system, especially the optic nerves and spinal cord. These attacks, ...

In the autoimmune disorder neuromyelitis optica (NMO), the immune system attacks the optic nerves and spinal cord. This can cause symptoms such as loss of vision and changes in sensation. Early and ...

Please provide your email address to receive an email when new articles are posted on . Ultomiris is a C5 complement inhibitor for neuromyelitis optica spectrum disorder. Trial patients did not ...